KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Receivables (2016 - 2025)

Astrana Health (ASTH) has disclosed Receivables for 15 consecutive years, with $400.8 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 31.22% to $400.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $400.8 million through Dec 2025, up 31.22% year-over-year, with the annual reading at $400.8 million for FY2025, 31.22% up from the prior year.
  • Receivables hit $400.8 million in Q4 2025 for Astrana Health, up from $391.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $400.8 million in Q4 2025 to a low of $14.3 million in Q1 2022.
  • Historically, Receivables has averaged $125.3 million across 5 years, with a median of $80.4 million in 2022.
  • Biggest YoY gain for Receivables was 957.56% in 2023; the steepest drop was 80.69% in 2023.
  • Year by year, Receivables stood at $20.3 million in 2021, then skyrocketed by 278.9% to $76.7 million in 2022, then dropped by 21.41% to $60.3 million in 2023, then skyrocketed by 406.48% to $305.5 million in 2024, then skyrocketed by 31.22% to $400.8 million in 2025.
  • Business Quant data shows Receivables for ASTH at $400.8 million in Q4 2025, $391.1 million in Q3 2025, and $357.4 million in Q2 2025.